Felbamate and Hypotension - a phase IV clinical study of FDA data

Summary:

Hypotension is reported as a side effect among people who take Felbamate (felbamate), especially for people who are male, 20-29 old, also take Midazolam, and have Seizures.

The phase IV clinical study analyzes which people have Hypotension when taking Felbamate. It is created by eHealthMe based on reports of 1,140 people who have side effects when taking Felbamate from the FDA, and is updated regularly.

What is Felbamate?

Felbamate has active ingredients of felbamate. eHealthMe is studying from 1,145 Felbamate users. Check the latest studies of Felbamate.

What is Hypotension?

Hypotension (abnormally low blood pressure) is found to be associated with 3,362 drugs and 4,754 conditions by eHealthMe. Check the latest studies of Hypotension.

On Jul, 11, 2026

1,140 people reported to have side effects when taking Felbamate.
Among them, 14 people (1.23%) have Hypotension.

Among these 14 people:

What is the gender of people who have Hypotension when taking Felbamate? *

female: 30.77 %
male: 69.23 %

What is the age of people who have Hypotension when taking Felbamate? *

What are other drugs people take besides Felbamate? *

What are other side effects people have besides Hypotension? *

Metabolic Acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body): 8 people, 57.14%
Cardiac Arrest: 8 people, 57.14%
Bradycardia (abnormally slow heart action): 7 people, 50.00%
Bundle Branch Block Right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle): 7 people, 50.00%
Hyperchloraemia (an excess of chlorides in the blood): 7 people, 50.00%
Blood Lactic Acid Increased: 5 people, 35.71%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 21.43%
Propofol Infusion Syndrome: 3 people, 21.43%
Dizziness: 3 people, 21.43%
Hyperkalemia (damage to or disease of the kidney): 2 people, 14.29%

What are the existing conditions these people have? *

Seizures (abnormal excessive or synchronous neuronal activity in the brain): 6 people, 42.86%
Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 4 people, 28.57%
Lennox-Gastaut Syndrome (epilepsy characterized by frequent seizures and different seizure types): 3 people, 21.43%
Colon Cancer: 1 person, 7.14%
Constipation: 1 person, 7.14%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 7.14%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 7.14%
Hypersensitivity: 1 person, 7.14%
Hypovolaemic Shock (shock caused by severe blood or fluid loss): 1 person, 7.14%
Lung Disorder (lung disease): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Felbamate and have Hypotension?

- Check whether Hypotension is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Felbamate:

Felbamate (1,145 reports)

Hypotension treatments and more:

Hypotension (329,856 reports)

Browse all side effects of Felbamate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypotension:

Hypotension (3,362 drugs)

Browse all the conditions that are associated with Hypotension:

Hypotension (4,754 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on felbamate (the active ingredients of Felbamate) and Felbamate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.